Edition:
United Kingdom

Neos Therapeutics Inc (NEOS.OQ)

NEOS.OQ on NASDAQ Stock Exchange Global Market

8.20USD
20 Apr 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$8.20
Open
$8.15
Day's High
$8.38
Day's Low
$8.15
Volume
27,290
Avg. Vol
77,309
52-wk High
$13.15
52-wk Low
$6.35

Select another date:

Tue, Feb 20 2018

BRIEF-Neos Therapeutics Reiterates Confidence In Strategic Plan And Value Creation Opportunities

* NEOS THERAPEUTICS REITERATES CONFIDENCE IN STRATEGIC PLAN AND VALUE CREATION OPPORTUNITIES

BRIEF-Jack Schuler Reports 8.1 Pct Passive Stake In Neos Therapeutics

* JACK SCHULER REPORTS 8.1 PERCENT PASSIVE STAKE IN NEOS THERAPEUTICS INC AS ON DECEMBER 31, 2017 - SEC FILING Source text: (http://bit.ly/2nOrQlw) Further company coverage:

BRIEF-Neos Therapeutics reports Q3 loss of $0.58/shr

* Neos Therapeutics reports third quarter 2017 financial results

BRIEF-PDL Biopharma urges Neos Therapeutics to provide update on sale process

* PDL Biopharma's proposal to acquire Neos Therapeutics expires today; PDL urges Neos to provide update on sale process

BRIEF-Neos Therapeutics receives paragraph IV certification from Teva Pharmaceuticals USA

* Neos Therapeutics-co received paragraph iv certification from teva pharmaceuticals usa that teva submitted anda for generic version of cotempla xr-odt​

Neos Therapeutics to consider other offers after PDL snub: sources

U.S. drugmaker Neos Therapeutics Inc , which this week rejected a fourth takeover offer by PDL Biopharma Inc , will consider offers from other potential buyers, according to people familiar with the matter.

CORRECTED-Neos Therapeutics to consider other offers after PDL snub -sources

Oct 31 U.S. drugmaker Neos Therapeutics Inc , which this week rejected a fourth takeover offer by PDL Biopharma Inc, will consider offers from other potential buyers, according to people familiar with the matter.

BRIEF-Neos Therapeutics‍ confirms it got unsolicited proposal from PDL Biopharma

* Says confirmed it received unsolicited proposal from PDL Biopharma to buy co for $10.25 per share in cash​

BRIEF-PDL BioPharma proposes to acquire Neos Therapeutics for $10.25 per share

* PDL Biopharma proposes to acquire NEOS THERAPEUTICS for $10.25 per share in cash

Select another date: